The life-saving work of a leading Monash University researcher, who examines the immune system to develop vaccines and fight disease, was today recognised with an award of merit in Canberra.
Head of Monash University’s Department of Immunology, Professor Fabienne Mackay, was one of 12 Australian researchers honoured with a prestigious Thomson Reuters Australia Citation Awardin recognition of research excellence.
Professor Mackay played a crucial role in the world’s first major lupus treatment breakthrough last year, a discovery that led directly to the development of a new preventative medication. This improved clinical outcome further validated a decade of Professor Mackay’s work on autoimmunity.
"I am pleased to be one of few in Australia to receive this award," Professor Mackay said.
“This award highlights the importance of research in this field, ultimately working toward improving patient outcomes through the development of vaccines and treatments.”
Professor Mackay expressed gratitude to the research community at Monash University for the support in building strong research capabilities.
"To those I have worked alongside over the years, I share my success and recognition through this award with you," Professor Mackay said.
Dean of the Faculty of Medicine, Nursing and Health Sciences, Professor Christina Mitchell congratulated Professor Mackay on her award.
“The pursuit of pioneering research in immunology is a science. Publishing research is an art. Professor Fabienne Mackay has outperformed in these dual spheres, ranking in the top half percentile of all publishing researchers in her field,” Professor Mitchell said.
“Inclusion in this category is a measure of the esteem in which other scientists hold her discoveries. At Monash we celebrate Professor Mackay's achievement and recognition through this Thomson Reuters Citation Award.”
For more information, contact Monash Media & Communications +61 3 9903 4840 or media@monash.edu.
